When: 15 September 2020 | 10:00 BST (GMT+1)
Overview
Russian pharmaceutical market has become an important growth engine for many pharmaceutical companies. Russia is one of five member states of the Eurasian Economic Union (EAEU). The newly created common pharmaceutical market of the EAEU introduced new regulatory requirements binding for all member states and aiming introduction of the best international practices.
At the webinar you will discover the implications of new requirements for on your current regulatory activities in Russia and will be able to outline a general regulatory strategy to enter and take advantage of the new EAEU platform.
Learning objectives
After attending this webinar participants will:
- Understand the general process of medicinal products surveillance in Russia
- Learn how Russian and the EAEU legislation overlaps
- Find out when the EAEU legislation substitutes Russian requirements
- Understand a basis of the EAEU submission: legal basis & pathways
- Learn about specifics of the EAEU dossier’ format and content
Target audience
Global, regional and local Regulatory Affairs professionals dealing with submissions in Russia and the Eurasian Economic Union (EAEU).
Speaker
Vlada Suslova
Regulatory Consultant
Vlada Suslova, a regulatory professional with a 16-year leadership and hands-on experience in RA in Russia, CIS, Eastern Europe, Middle East and Africa. Vlada has led a project devoted to the remediation of dossiers in line with the EAEU requirements in Bayer Consumer Care.
CPD
This course offers 1 CPD hours for successful completion. To learn why CPD is important visit our Lifelong Learning page.
How do I register?
Prices
Type |
Member |
Non-member |
Standard |
£70 + VAT |
£95 + VAT |
Discounted Places
A limited number of discounted places are available at the rates below for those:
Please email meetings@topra.org for a discount code before making your booking.
Type |
Member |
Non-member |
Discount |
£35 + VAT* |
£47.50 + VAT* |
* VAT, if applicable, is charged at a rate of 20%.
Terms and conditions
By purchasing this webinar, you are agreeing to the terms and conditions.